Investigating the best use of laser therapy for glaucoma treatment
Clarifying the Optimal Application of SLT Therapy (COAST)
['FUNDING_OTHER'] · WEST VIRGINIA UNIVERSITY · NIH-10912595
This study is looking at how well a special laser treatment called selective laser trabeculoplasty (SLT) works for people with open-angle glaucoma, to see if it can help reduce the need for daily eye drops and make it easier for patients to stick to their treatment plans.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WEST VIRGINIA UNIVERSITY (nih funded) |
| Locations | 1 site (MORGANTOWN, UNITED STATES) |
| Trial ID | NIH-10912595 on ClinicalTrials.gov |
What this research studies
This research focuses on open-angle glaucoma (OAG) and explores the effectiveness of selective laser trabeculoplasty (SLT) as a primary treatment option. It aims to determine the optimal application of SLT therapy, particularly in terms of energy levels and frequency of treatment, to improve patient outcomes. By comparing SLT to traditional medical therapies, the study seeks to provide insights into how laser treatment can reduce the need for daily medications and enhance adherence among patients. The research will analyze data from previous trials and patient responses to establish best practices for SLT application.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with open-angle glaucoma who may benefit from laser therapy as a primary treatment.
Not a fit: Patients with glaucoma who are already effectively managed with medical therapy or those with advanced glaucoma requiring surgical intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols for glaucoma, potentially reducing the need for daily medications and enhancing patient quality of life.
How similar studies have performed: Previous research has shown promising results for SLT as a treatment for glaucoma, indicating that this approach could lead to significant advancements in patient care.
Where this research is happening
MORGANTOWN, UNITED STATES
- WEST VIRGINIA UNIVERSITY — MORGANTOWN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: REALINI, ANTHONY — WEST VIRGINIA UNIVERSITY
- Study coordinator: REALINI, ANTHONY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.